We are live on ! Find out more
OPPM

Opus Point Partners Management Portfolio holdings

AUM $55.3M
1-Year Est. Return 7.48%
This Fund
S&P 500
This Quarter Est. Return
-5.05%
1 Year Est. Return
-7.48%
3 Year Est. Return
+85.18%
5 Year Est. Return
+168.21%
10 Year Est. Return
–
AUM
$126M
AUM Growth
-$52.8M
Cap. Flow
+$7.71M
Cap. Flow %
6.14%
Top 10 Hldgs %
48.85%
Holding
64
New
14
Increased
25
Reduced
1
Closed
7

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$1.83M
2
TSRO
TESARO, Inc.
TSRO
+$1.26M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$1.06M
4
BMY icon
Bristol-Myers Squibb
BMY
+$783K
5
SCTL
Societal CDMO, Inc. Common Stock
SCTL
+$305K

Top Sells

Rank Stock Value
1
SDS icon
ProShares UltraShort S&P500
SDS
+$656K
2
CPHD
Cepheid Inc
CPHD
+$315K
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$311K
4
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$208K
5
NVAX icon
Novavax
NVAX
+$54K

Sector Composition

Rank Sector Weight
1 Healthcare 65.26%
2 Miscellaneous 34.09%
3 Real Estate 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGEN icon
51
Precigen
PGEN
$2.57B
$240K 0.19%
+9,964
New +$277K
AVXS
52
DELISTED
AveXis, Inc. Common Stock
AVXS
$239K 0.19%
+5,000
New +$267K
NBIX icon
53
Neurocrine Biosciences
NBIX
$15.8B
$238K 0.19%
6,137
+2,069
+51% +$93.7K
MYGN icon
54
Myriad Genetics
MYGN
$304M
$232K 0.18%
+13,907
New +$252K
ICPT
55
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$232K 0.18%
2,135
+829
+63% +$98.8K
JUNO
56
DELISTED
Juno Therapeutics, Inc.
JUNO
$216K 0.17%
11,478
+4,560
+66% +$112K
MCRB icon
57
Seres Therapeutics
MCRB
$49.7M
$139K 0.11%
700
– –
IWM icon
58
PUT
iShares Russell 2000 ETF
IWM
$81.9B
– –
-350,000
Closed -$43.5M
NVAX icon
59
Novavax
NVAX
$1.49B
– –
-1,289
Closed -$54K
SDS icon
60
ProShares UltraShort S&P500
SDS
$391M
– –
-400
Closed -$656K
XBI icon
61
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.7B
– –
-430,400
Closed -$28.5M
ISEE
62
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-6,746
Closed -$311K
SIOX
63
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-1,856
Closed -$208K
CPHD
64
DELISTED
Cepheid Inc
CPHD
– –
-5,985
Closed -$315K
1 2
3

Similar funds

KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
DP
DW Partners New York $62.3M AUM 25.52% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return

Opus Point Partners Management's Q4 2016 Portfolio in Review

As of Q4 2016, Opus Point Partners Management held 64 positions worth $126M, down 30% from $178M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Opus Point Partners Management deployed $7.71M of net new capital in Q4 2016, opening 14 new positions and adding to 25 existing holdings. Its largest new stake was TESARO, Inc.: 10,000 shares worth $1.34M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 44% a quarter earlier, followed by Miscellaneous and Real Estate.

On the sell side, the largest reduction was Direxion Daily S&P Biotech Bull 3X ETF, an estimated $12.8K trimmed.

  • Opus Point Partners Management's largest Q4 2016 buy was TESARO, Inc.: 10,000 shares worth $1.34M.
  • Opus Point Partners Management added most to Alnylam Pharmaceuticals in Q4 2016, an estimated $1.83M increase.
  • Opus Point Partners Management's biggest Q4 2016 reduction was Direxion Daily S&P Biotech Bull 3X ETF, cutting an estimated $12.8K.
  • Opus Point Partners Management fully exited ProShares UltraShort S&P500 in Q4 2016, selling an estimated $656K.
  • Opus Point Partners Management's ten largest holdings make up 49% of its $126M portfolio in Q4 2016.
  • Opus Point Partners Management opened 14 new positions and closed 7 in Q4 2016.
  • Opus Point Partners Management's portfolio value fell 30% quarter-over-quarter to $126M.

Based on Opus Point Partners Management's 13F filing for Q4 2016, filed 14 Feb 2017.